Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Schering-Plough Corp. (SGP)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
1 new
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: SGP
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on SGP
The Real Price of Big Pharma's Huge Fines
[View article]
How about removing the "off-label" promoted drugs off Medicare/Medicaid formularies? This is the ultimate wake-up call!
Comment by
Buckeye Jim
Nov 10 23:54 pm
|
Rating:
0
0
The Real Price of Big Pharma's Huge Fines
[View article]
How about 5 years or fine equal to total compensation received for the past 5 years? After the first couple of convictions, everyone...
More »
Comment by
Suzit
Nov 10 13:10 pm
|
Rating:
0
0
The Real Price of Big Pharma's Huge Fines
[View article]
DDMAC warning letters from FDA are always addressed to the CEO, but merely admonish the company to take corrective actions. If those...
More »
Comment by
pharmaveteran
Nov 10 10:47 am
|
Rating:
0
0
The Real Price of Big Pharma's Huge Fines
[View article]
So true Mr. Lowe, so true. While criminal penalties would definitely have an impact, most people would think the penalty...
More »
Comment by
policy_redux
Nov 10 09:39 am
|
Rating:
0
0
The Real Price of Big Pharma's Huge Fines
[View article]
The real solution is to put some corporate officers in jail--when monetary penalties are meaningless we need to look at other forms of...
More »
Comment by
User 450353
Nov 10 08:53 am
|
Rating:
+2
0
The Real Price of Big Pharma's Huge Fines
[View article]
How true!!!! The old saying in the industry 20 years ago was that Pfizer never let science get in the way of marketing. Afterall, if...
More »
Comment by
idlut
Nov 10 08:01 am
|
Rating:
0
0
Johnson & Johnson: The Elephant in the Merck-Schering Living Room
[View article]
This is a big issue that seems to garner little attention at the moment for JNJ. It is a heads i win, tails i don't lose anything...
More »
Comment by
Frank Waddell
Nov 5 10:41 am
|
Rating:
+2
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
How do explain the fact that US Pharma companies spend 2 - 3 times in BME (business development, advertising, marketing and lobbying)...
More »
Comment by
E Nuff Sed
Nov 2 23:03 pm
|
Rating:
+1
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
Listen Grandad. Pharma research is exactly like defense. In the past, the U.S. has defended the rest of the world because the other...
More »
Comment by
Steve in Greensboro
Nov 1 22:19 pm
|
Rating:
0
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
c smith: if you have that private pay data readily available for the other companies, that would be good data to share
Comment by
Richard Shaw
Nov 1 11:03 am
|
Rating:
0
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
c smith: nice point
Comment by
Richard Shaw
Nov 1 10:40 am
|
Rating:
0
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
A better measure of sensitivity to ObamaCare is percentage of revenue which is "private pay"; i.e.; that which is not publicly funded...
More »
Comment by
c smith
Oct 31 20:37 pm
|
Rating:
+1
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
Herbal or alternative or fringe etc. medications are not the issue. Hard science pharma (or a reasonable facsimile in view of the...
More »
Comment by
searcher
Oct 31 14:58 pm
|
Rating:
+1
0
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
I suspect the concern raised by the author is overblown. Other than adding more lives to be insured and saddling the taxpayer with more...
More »
Comment by
skwestorange
Oct 31 14:39 pm
|
Rating:
+1
-1
Healthcare Profits: Assessing Company Sensitivity to Obamacare
[View article]
The FDA just sent a threatening letter to Dr. Weil for advocating use of an herbal preparation that many use and have reported benefit...
More »
Comment by
Jade Queen
Oct 31 12:18 pm
|
Rating:
0
-2
1
2
3
4
5
6
7
8
9
10
...
59
60
Next Page
The Real Price of Big Pharma's Huge Fines [View article]
The Real Price of Big Pharma's Huge Fines [View article]
The Real Price of Big Pharma's Huge Fines [View article]
The Real Price of Big Pharma's Huge Fines [View article]
The Real Price of Big Pharma's Huge Fines [View article]
The Real Price of Big Pharma's Huge Fines [View article]
Johnson & Johnson: The Elephant in the Merck-Schering Living Room [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]
Healthcare Profits: Assessing Company Sensitivity to Obamacare [View article]